M. Demirel Et Al. , "Use of Recombinant Factor VIIa for Bleeding Control in Treatment of Acute Extremity Compartment Syndrome Secondary to Primary Myelofibrosis: A Case Report.," JBJS case connector , vol.11, no.3, 2021
Demirel, M. Et Al. 2021. Use of Recombinant Factor VIIa for Bleeding Control in Treatment of Acute Extremity Compartment Syndrome Secondary to Primary Myelofibrosis: A Case Report.. JBJS case connector , vol.11, no.3 .
Demirel, M., Kendirci, A. Ş., Özmen, E., & Polat, G., (2021). Use of Recombinant Factor VIIa for Bleeding Control in Treatment of Acute Extremity Compartment Syndrome Secondary to Primary Myelofibrosis: A Case Report.. JBJS case connector , vol.11, no.3.
Demirel, Mehmet Et Al. "Use of Recombinant Factor VIIa for Bleeding Control in Treatment of Acute Extremity Compartment Syndrome Secondary to Primary Myelofibrosis: A Case Report.," JBJS case connector , vol.11, no.3, 2021
Demirel, Mehmet Et Al. "Use of Recombinant Factor VIIa for Bleeding Control in Treatment of Acute Extremity Compartment Syndrome Secondary to Primary Myelofibrosis: A Case Report.." JBJS case connector , vol.11, no.3, 2021
Demirel, M. Et Al. (2021) . "Use of Recombinant Factor VIIa for Bleeding Control in Treatment of Acute Extremity Compartment Syndrome Secondary to Primary Myelofibrosis: A Case Report.." JBJS case connector , vol.11, no.3.
@article{article, author={Mehmet DEMİREL Et Al. }, title={Use of Recombinant Factor VIIa for Bleeding Control in Treatment of Acute Extremity Compartment Syndrome Secondary to Primary Myelofibrosis: A Case Report.}, journal={JBJS case connector}, year=2021}